ORIC Pharmaceuticals, Inc. (ORIC) Tops Q2 EPS by 7c
Get Alerts ORIC Hot Sheet
Join SI Premium – FREE
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Noodles & Company (NDLS) Tops Q2 EPS by 26c ; Offers Guidance
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share